Gene: ANKRD36B
Official Full Name: ankyrin repeat domain 36Bprovided by HGNC
Gene Summary: Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19832 | ANKRD36B Knockout cell line (HeLa) | Human | ANKRD36B | 1:3~1:6 | Negative | Online Inquiry |
KO19833 | ANKRD36B Knockout cell line (HCT 116) | Human | ANKRD36B | 1:2~1:4 | Negative | Online Inquiry |
KO19834 | ANKRD36B Knockout cell line (HEK293) | Human | ANKRD36B | 1:3~1:6 | Negative | Online Inquiry |
KO19835 | ANKRD36B Knockout cell line (A549) | Human | ANKRD36B | 1:3~1:4 | Negative | Online Inquiry |
ANKRD36B Gene Knockout Cell Lines are customized, genetically engineered cell lines in which the ANKRD36B gene has been specifically disrupted or inactivated, allowing researchers to study the role of this gene in various biological processes. These cell lines serve as powerful tools for investigating gene function, disease mechanisms, and potential therapeutic strategies.
The core function of ANKRD36B is believed to be involved in cellular signaling pathways and gene regulation, making it crucial for understanding fundamental cellular processes such as differentiation, cell growth, and response to environmental stimuli. By using these knockout cell lines, scientists can elucidate the specific contributions of ANKRD36B in various contexts, including cancer biology, immunology, and regenerative medicine. The knockout mechanism typically involves CRISPR/Cas9 technology or similar genome editing techniques, allowing for precise targeting of the gene and minimizing off-target effects, which enhances the reliability of experimental outcomes.
The scientific importance of ANKRD36B Gene Knockout Cell Lines cannot be overstated, as they are essential in both basic research and clinical applications. In research settings, they facilitate the identification of biological pathways and potential therapeutic targets. Clinically, understanding the implications of ANKRD36B can contribute to the development of personalized medicine approaches, particularly in diseases where this gene plays a significant role.
Compared to alternatives such as wild-type cell lines or conventional gene knockdown methods, ANKRD36B Gene Knockout Cell Lines offer more precise gene alteration and are less influenced by residual gene expression. This specificity significantly enhances experimental accuracy and reproducibility, thus providing researchers with more conclusive data.
For researchers and clinicians, the valuable insights derived from using these knockout cell lines can accelerate discovery and innovation. The ability to dissect gene function in a targeted manner supports endeavors in drug development and the understanding of complex disease pathways.
Our company specializes in the development of high-quality, genetically modified cell lines, underscoring our commitment to supporting cutting-edge research and advancing scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.